GeneDx Partners With Epic to Expand Access to Testing Services in Neonatal ICUs-February 2024-www.financetom.com

GeneDx Partners With Epic to Expand Access to Testing Services in Neonatal ICUs

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

GeneDx Partners With Epic to Expand Access to Testing Services in Neonatal ICUs

Jun 10, 2024 7:02 AM

09:31 AM EDT, 06/10/2024 (MT Newswires) -- GeneDx Holdings ( WGS ) said Monday it is collaborating with Epic to expand its rapid whole genome sequencing services in neonatal intensive care units.

The integration with Epic allows GeneDX ( WGS ) to directly connect with health systems that have Epic's electronic health records for receiving orders and sending results, GeneDx ( WGS ) said.

Financial terms of the collaboration weren't disclosed.

Price: 24.53, Change: -0.48, Percent Change: -1.92

Previous page： Urban Outfitters Reports Q2 Results: Strong EPS, Record Quarterly Sales Next page： SIGA Technologies Wins $9 Million Antiviral Drug Procurement Contract From Defense Department

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Urban Outfitters Reports Q2 Results: Strong EPS, Record Quarterly Sales

Aug 22, 2024

Urban Outfitters, Inc. ( URBN ) reported better-than-expected second-quarter financial results after Wednesday's closing bell. Here's a look at the key figures from the quarter. The Details: Urban Outfitters ( URBN ) reported quarterly earnings of $1.24 per share, which beat the analyst consensus estimate of $1.01 by 22.77%. The company announced record quarterly sales of $1.35 billion, which beat...

SIGA Technologies Wins $9 Million Antiviral Drug Procurement Contract From Defense Department

Aug 22, 2024

04:47 PM EDT, 08/21/2024 (MT Newswires) -- SIGA Technologies ( SIGA ) said Wednesday it received a roughly $9 million order from the US Department of Defense for its antiviral drug TPOXX, also known as tecovirimat. The order comprises mainly oral TPOXX and a small amount of intravenous TPOXX intended to protect military personnel against orthopoxvirus risks, such as smallpox,...

Snowflake Fiscal Q2 Non-GAAP Earnings Drop, Revenue Rises -- Shares Down After Hours

Aug 22, 2024

04:45 PM EDT, 08/21/2024 (MT Newswires) -- Snowflake (SNOW) late Wednesday reported non-GAAP fiscal Q2 net income of $0.18 per diluted share, down from $0.22 a year earlier. Analysts polled by Capital IQ expected $0.16. Revenue for the quarter ended July 31 was $868.8 million, compared with $674 million a year earlier. Analysts expected $850.7 million. The company's board approved...

Paramount takeover saga heats up as Edgar Bronfman Jr places bid

Aug 22, 2024

(Reuters) - Veteran media executive Edgar Bronfman Jr. has sweetened his bid to take over Paramount Global, offering $6 billion for its controlling shareholder National Amusements and a minority stake in Paramount. Bronfman's original offer was for $4.3 billion, according to Reuters sources. The competing offer for the home of Paramount Pictures, the CBS broadcast network and cable networks such...